Horsetalk.co.nz - Full Article
August 2, 2017
Horsetalk.co.nz
A rider from Bahrain has been suspended from competition for six months and fined 2000 Swiss francs after his endurance mount tested positive to five substances not permitted under FEI equine anti-doping rules.
The Bahrain-registered horse Ultreia Larzac, ridden by Othman Abduljaleel Al Awadhi, competed in the CEI2* 120km ride at the Bahrain International Endurance Village, Sakhir, on January 14 this year.
The horse was selected for drug testing. The blood sample revealed the presence of caffeine, theophylline, phenylbutazone, oxyphenbutazone, and dexamethasone.
Caffeine is a central nervous system stimulant. Theophylline is used to open airways in the treatment of respiratory disease. Phenylbutazone and its metabolic byproduct oxyphenbutazone are non-steroidal anti-inflammatory drugs with painkilling effects. Dexamethasone is a corticosteroid drug with anti-inflammatory effects...
Read more at https://www.horsetalk.co.nz/2017/08/02/rider-bahrain-suspension-fine-endurance-horse/#OoSjzXMdLBQybC4j.99
Tribute to Becky Hart: Champion Endurance Athlete and Equestrian Educator
Bob Langrish photo USEF.org As an athlete, coach, and leader in the sport, Becky Hart had a profound impact on endurance riding in the U...
-
Inside.fei.org 17 December 2020 The FEI Board took a series of key decisions on allocation, cancellation, and reopening of bids for FEI C...
-
Inside.FEI.org 02 September 2024 Author: Mirjam van Huet A total of 145 athletes and 155 horses are currently preparing for the journe...
-
WAM.ae 02/09/2023 CASTELSAGRAT, France, 2nd September, 2023 (WAM) – The UAE Saturday won the FEI Endurance World Championship for Young R...
